These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 33147167)
1. Dexmedetomidine inhibits inflammatory response and autophagy through the circLrp1b/miR-27a-3p/Dram2 pathway in a rat model of traumatic brain injury. Li H; Lu C; Yao W; Xu L; Zhou J; Zheng B Aging (Albany NY); 2020 Nov; 12(21):21687-21705. PubMed ID: 33147167 [TBL] [Abstract][Full Text] [Related]
2. Circular RNA cerebellar degeneration-related protein 1 antisense RNA (Circ-CDR1as) downregulation induced by dexmedetomidine treatment protects hippocampal neurons against hypoxia/reoxygenation injury through the microRNA-28-3p (miR-28-3p)/tumor necrosis factor receptor-associated factor-3 (TRAF3) axis. Wang J; Wang Y Bioengineered; 2021 Dec; 12(2):10512-10524. PubMed ID: 34787053 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of miR-27a against traumatic brain injury via suppressing FoxO3a-mediated neuronal autophagy. Sun L; Zhao M; Wang Y; Liu A; Lv M; Li Y; Yang X; Wu Z Biochem Biophys Res Commun; 2017 Jan; 482(4):1141-1147. PubMed ID: 27919684 [TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Inhibits Inflammation to Alleviate Early Neuronal Injury via TLR4/NF-κB Pathway in Rats with Traumatic Brain Injury. Huang GR; Hao FG Crit Rev Eukaryot Gene Expr; 2021; 31(1):41-47. PubMed ID: 33639054 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of rno_circRNA_009194 Improves Outcomes in Traumatic Brain Injury Rats through Inhibiting Voltage-Gated Sodium Channel Nav1.3. Huang XJ; Su GJ; Wu CW; Sha XS; Zou JF; Liu XS; Li M; He Y J Neurotrauma; 2022 Jan; 39(1-2):196-210. PubMed ID: 34726508 [TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS/Nrf2 signaling pathway. Feng X; Ma W; Zhu J; Jiao W; Wang Y Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278508 [TBL] [Abstract][Full Text] [Related]
7. Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth Huang S; Ge X; Yu J; Han Z; Yin Z; Li Y; Chen F; Wang H; Zhang J; Lei P FASEB J; 2018 Jan; 32(1):512-528. PubMed ID: 28935818 [TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine Attenuates Neuroinflammatory-Induced Apoptosis after Traumatic Brain Injury via Nrf2 signaling pathway. Li F; Wang X; Zhang Z; Zhang X; Gao P Ann Clin Transl Neurol; 2019 Sep; 6(9):1825-1835. PubMed ID: 31478596 [TBL] [Abstract][Full Text] [Related]
9. Administration of Dexmedetomidine inhibited NLRP3 inflammasome and microglial cell activities in hippocampus of traumatic brain injury rats. Zheng B; Zhang S; Ying Y; Guo X; Li H; Xu L; Ruan X Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30232232 [TBL] [Abstract][Full Text] [Related]
10. Increased miR-21-3p in Injured Brain Microvascular Endothelial Cells after Traumatic Brain Injury Aggravates Blood-Brain Barrier Damage by Promoting Cellular Apoptosis and Inflammation through Targeting MAT2B. Ge X; Li W; Huang S; Yin Z; Yang M; Han Z; Han Z; Chen F; Wang H; Lei P; Zhang J J Neurotrauma; 2019 Apr; 36(8):1291-1305. PubMed ID: 29695199 [TBL] [Abstract][Full Text] [Related]
11. miR-23b improves cognitive impairments in traumatic brain injury by targeting ATG12-mediated neuronal autophagy. Sun L; Liu A; Zhang J; Ji W; Li Y; Yang X; Wu Z; Guo J Behav Brain Res; 2018 Mar; 340():126-136. PubMed ID: 27630106 [TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine reduces oxidative stress and provides neuroprotection in a model of traumatic brain injury via the PGC-1α signaling pathway. Li F; Wang X; Deng Z; Zhang X; Gao P; Liu H Neuropeptides; 2018 Dec; 72():58-64. PubMed ID: 30396595 [TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of α7nAChR and PI3K/Akt- mediated autophagy. Yu T; Liu D; Gao M; Yang P; Zhang M; Song F; Zhang X; Liu Y Biomed Pharmacother; 2019 Dec; 120():109231. PubMed ID: 31546082 [TBL] [Abstract][Full Text] [Related]
14. Increases in miR-124-3p in Microglial Exosomes Confer Neuroprotective Effects by Targeting FIP200-Mediated Neuronal Autophagy Following Traumatic Brain Injury. Li D; Huang S; Yin Z; Zhu J; Ge X; Han Z; Tan J; Zhang S; Zhao J; Chen F; Wang H; Lei P Neurochem Res; 2019 Aug; 44(8):1903-1923. PubMed ID: 31190315 [TBL] [Abstract][Full Text] [Related]
15. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway. Chen Q; Liu T; Bao Y; Zhao T; Wang J; Wang H; Wang A; Gan X; Wu Z; Wang L Cancer Lett; 2020 Jan; 469():68-77. PubMed ID: 31629934 [TBL] [Abstract][Full Text] [Related]
16. TUG1 Represses Apoptosis, Autophagy, and Inflammatory Response by Regulating miR-27a-3p/SLIT2 in Lipopolysaccharide-Treated Vascular Endothelial Cells. Dong Y; Fan G; Li Y; Zhou Q J Surg Res; 2020 Dec; 256():345-354. PubMed ID: 32738556 [TBL] [Abstract][Full Text] [Related]
17. [Activation of miR-124-3p/Notch pathway promotes proliferation and differentiation of rat neural stem cells after traumatic brain injury]. Bai W; Zhang X; Su X; Kong C; Yang Y; Ye Y; Fan Z; He X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan; 36(1):49-55. PubMed ID: 32314724 [TBL] [Abstract][Full Text] [Related]
18. Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy. Jin X; Gao J; Zheng R; Yu M; Ren Y; Yan T; Huang Y; Li Y Cell Death Dis; 2020 Feb; 11(2):123. PubMed ID: 32054840 [TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine Protects Against Traumatic Brain Injury-Induced Acute Lung Injury in Mice. Wang Y; Wang C; Zhang D; Wang H; Bo L; Deng X Med Sci Monit; 2018 Jul; 24():4961-4967. PubMed ID: 30013022 [TBL] [Abstract][Full Text] [Related]
20. Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury. Karakaya D; Cakir-Aktas C; Uzun S; Soylemezoglu F; Mut M Neurocrit Care; 2022 Jun; 36(3):802-814. PubMed ID: 34782991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]